Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

MicroRNA expression profiles from three arterial tortuosity syndrome (ATS) patients' skin fibroblasts with recessive SLC2A10 mutations [miRNA]


ABSTRACT: To screen for potential miRNA that may contribute to the pathomechanisms of ATS miRNA expression profiling using the Affymetrix GeneChip® miRNA 3.0 Array comparing the miRNA expression changes of skin fibroblasts of three ATS patients with those of three healthy individuals Comparison of miRNA expression profiles between three ATS human fibroblasts and three healthy individuals

ORGANISM(S): Homo sapiens

SUBMITTER: Nicola Chiarelli 

PROVIDER: E-GEOD-71172 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

GLUT10 deficiency leads to oxidative stress and non-canonical αvβ3 integrin-mediated TGFβ signalling associated with extracellular matrix disarray in arterial tortuosity syndrome skin fibroblasts.

Zoppi Nicoletta N   Chiarelli Nicola N   Cinquina Valeria V   Ritelli Marco M   Colombi Marina M  

Human molecular genetics 20150916 23


Arterial tortuosity syndrome (ATS) is an autosomal recessive connective tissue disorder caused by loss-of-function mutations in SLC2A10, which encodes facilitative glucose transporter 10 (GLUT10). The role of GLUT10 in ATS pathogenesis remains an enigma, and the transported metabolite(s), i.e. glucose and/or dehydroascorbic acid, have not been clearly elucidated. To discern the molecular mechanisms underlying the ATS aetiology, we performed gene expression profiling and biochemical studies on sk  ...[more]

Similar Datasets

2015-09-21 | E-GEOD-70683 | biostudies-arrayexpress
2015-09-21 | GSE71172 | GEO
2014-06-10 | E-GEOD-58312 | biostudies-arrayexpress
2015-09-21 | GSE70683 | GEO
2016-08-05 | E-GEOD-77756 | biostudies-arrayexpress
| PRJNA290495 | ENA
2013-03-28 | E-GEOD-45516 | biostudies-arrayexpress
2009-12-05 | E-GEOD-19262 | biostudies-arrayexpress
2016-08-05 | E-GEOD-77753 | biostudies-arrayexpress
| PRJNA289351 | ENA